Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Working Capital Changes: 2016-2024

Historic Other Working Capital Changes for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $2.5 million.

  • Organogenesis Holdings' Other Working Capital Changes fell 366.70% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 81.45%. This contributed to the annual value of $2.5 million for FY2024, which is 74.80% down from last year.
  • Organogenesis Holdings' Other Working Capital Changes amounted to $2.5 million in FY2024, which was down 74.80% from $10.1 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Other Working Capital Changes registered a high of $10.1 million during FY2023, and its lowest value of $34,000 during FY2021.
  • Its 3-year average for Other Working Capital Changes is $4.3 million, with a median of $2.5 million in 2024.
  • In the last 5 years, Organogenesis Holdings' Other Working Capital Changes plummeted by 90.42% in 2021 and then surged by 2,575.93% in 2023.
  • Organogenesis Holdings' Other Working Capital Changes (MRY) stood at $355,000 in 2020, then crashed by 90.42% to $34,000 in 2021, then soared by 1,011.76% to $378,000 in 2022, then surged by 2,575.93% to $10.1 million in 2023, then tumbled by 74.80% to $2.5 million in 2024.
  • Its Other Working Capital Changes was $2.5 million in FY2024, compared to $10.1 million in FY2023 and $378,000 in FY2022.